Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesia
Europace · 30.03.2024 · 26 (4)
DOI: 10.1093/europace/euae074 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Europace, online erschienen am 26.03.2024. Verfasst von Veronica Dusi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126 Torino, Italy. Hauptthemen laut MEDLINE: Stellate Ganglion, Anesthesia, Epidural, Autonomic Nerve Block. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union's Horizon-2020 research and innovation programme.
Abstract (Originalsprache)
Aims
Percutaneous stellate ganglion block (PSGB) through single-bolus injection and thoracic epidural anaesthesia (TEA) have been proposed for the acute management of refractory ventricular arrhythmias (VAs). However, data on continuous PSGB (C-PSGB) are scant. The aim of this study is to report our dual-centre experience with C-PSGB and to perform a systematic review on C-PSGB and TEA. Methods and results Consecutive patients receiving C-PSGB at two centres were enrolled. The systematic literature review follows the latest Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. Our case series (26 patients, 88% male, 60 ± 16 years, all with advanced structural heart disease, left ventricular ejection fraction 23 ± 11%, 32 C-PSGBs performed, with a median duration of 3 days) shows that C-PSGB is feasible and safe and leads to complete VAs suppression in 59% and to overall clinical benefit in 94% of cases. Overall, 61 patients received 68 C-PSGBs and 22 TEA, with complete VA suppression in 63% of C-PSGBs (61% of patients). Most TEA procedures (55%) were performed on intubated patients, as opposed to 28% of C-PSGBs (P = 0.02); 63% of cases were on full anticoagulation at C-PSGB, none at TEA (P < 0.001). Ropivacaine and lidocaine were the most used drugs for C-PSGB, and the available data support a starting dose of 12 and 100 mg/h, respectively. No major complications occurred, yet TEA discontinuation rate due to side effects was higher than C-PSGB (18 vs. 1%, P = 0.01).
Conclusion
Continuous PSGB seems feasible, safe, and effective for the acute management of refractory VAs. The antiarrhythmic effect may be accomplished with less concerns for concomitant anticoagulation compared with TEA and with a lower side-effect related discontinuation rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126 Torino, Italy.
- Division of Cardiology, Cardiovascular and Thoracic Department, 'Città della Salute e della Scienza' Hospital, Corso Bramante 88/90, 10126 Torino, Italy.
- Arrhythmia and Electrophysiology Unit, Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Anaesthesia, Critical Care and Emergency, 'Città della Salute e della Scienza' Hospital, Torino, Italy.
- Department of Molecular Medicine, Section of Cardiology, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy.
- Department of Surgical Sciences, University of Turin, Torino, Italy.
ORCID-Profile: Veronica Dusi, Filippo Angelini, Enrico Baldi, Antonio Toscano, Carol Gravinese, Simone Frea, Sara Compagnoni, Arianna Morena, Andrea Saglietto, Eleonora Balzani, Matteo Giunta, Andrea Costamagna, Roberto Rordorf, Matteo Anselmino, Simone Savastano, Gaetano Maria De Ferrari
Förderung
- European Union's Horizon-2020 research and innovation programme
Zitieren
APA
Dusi, V., Angelini, F., Baldi, E., Toscano, A., Gravinese, C., Frea, S., Compagnoni, S., Morena, A., Saglietto, A., Balzani, E., Giunta, M., Costamagna, A., Rinaldi, M., Trompeo, A. C., Rordorf, R., Anselmino, M., Savastano, S., & De Ferrari, G. M. (2024). Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesia. Europace, 26(4). https://doi.org/10.1093/europace/euae074
Vancouver
Dusi V, Angelini F, Baldi E, Toscano A, Gravinese C, Frea S, et al. Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesia. Europace. 2024;26(4). doi:10.1093/europace/euae074
BibTeX
@article{Dusi2024,
author = {Dusi, Veronica and Angelini, Filippo and Baldi, Enrico and Toscano, Antonio and Gravinese, Carol and Frea, Simone and Compagnoni, Sara and Morena, Arianna and Saglietto, Andrea and Balzani, Eleonora and Giunta, Matteo and Costamagna, Andrea and Rinaldi, Mauro and Trompeo, Anna Chiara and Rordorf, Roberto and Anselmino, Matteo and Savastano, Simone and De Ferrari, Gaetano Maria},
title = {Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesia},
journal = {Europace},
year = {2024},
volume = {26},
number = {4},
doi = {10.1093/europace/euae074}
}
EUVIMED